Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
J Neuroendocrinol ; 16(3): 272-8, 2004 Mar.
Article in English | MEDLINE | ID: mdl-15049858

ABSTRACT

The hormonal response to stress is enhanced by oestrogen but inhibited by androgens. To determine underlying changes in activity of neuropeptide neurones in the paraventricular nucleus of the hypothalamus (PVN), we examined the effect of oestrogen and androgen treatment on restraint-induced c-fos mRNA, corticotropin-releasing hormone (CRH) heteronuclear RNA, and arginine vasopressin hnRNA expression in the PVN. Male rats were gonadectomized and injected with oestradiol benzoate (EB) or dihydrotestosterone propionate (DHTP; s.c., daily for 4 days). Rats were stressed by restraint for 10 min or 30 min before killing. Other rats were stressed for 30 min and then returned to their home cage for 20 min before killing. Corticosterone and adrenocorticotropic hormone responses to restraint stress were significantly greater in EB-treated rats and lower in DHTP-treated rats at the 30-min timepoint compared to controls. c-fos mRNA increases following stress were augmented by EB but inhibited by DHTP. CRH hnRNA expression increased significantly in the PVN in response to restraint stress, and this increase was augmented by EB treatment, but decreased by DHTP treatment. Vasopressin hnRNA expression was also increased in response to stress, and this increase was attenuated by DHTP. These findings indicate that gonadal hormones influence the reactivity of the hypothalamic-pituitary adrenal axis to stress.


Subject(s)
Adrenocorticotropic Hormone/blood , Corticosterone/blood , Dihydrotestosterone/analogs & derivatives , Dihydrotestosterone/pharmacology , Estradiol/analogs & derivatives , Estradiol/physiology , Paraventricular Hypothalamic Nucleus/metabolism , Stress, Psychological/metabolism , Animals , Arginine Vasopressin/genetics , Arginine Vasopressin/metabolism , Corticotropin-Releasing Hormone/genetics , Corticotropin-Releasing Hormone/metabolism , Hypothalamo-Hypophyseal System/physiology , Male , Neurons/drug effects , Neurons/metabolism , Paraventricular Hypothalamic Nucleus/cytology , Paraventricular Hypothalamic Nucleus/drug effects , Pituitary-Adrenal System/physiology , Proto-Oncogene Proteins c-fos/genetics , Proto-Oncogene Proteins c-fos/metabolism , RNA, Messenger/analysis , Rats , Rats, Sprague-Dawley , Restraint, Physical
2.
Nat Med ; 7(4): 471-7, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11283675

ABSTRACT

During ischemic stroke, neurons at risk are exposed to pathologically high levels of intracellular calcium (Ca++), initiating a fatal biochemical cascade. To protect these neurons, we have developed openers of large-conductance, Ca++-activated (maxi-K or BK) potassium channels, thereby augmenting an endogenous mechanism for regulating Ca++ entry and membrane potential. The novel fluoro-oxindoles BMS-204352 and racemic compound 1 are potent, effective and uniquely Ca++-sensitive openers of maxi-K channels. In rat models of permanent large-vessel stroke, BMS-204352 provided significant levels of cortical neuroprotection when administered two hours after the onset of occlusion, but had no effects on blood pressure or cerebral blood flow. This novel approach may restrict Ca++ entry in neurons at risk while having minimal side effects.


Subject(s)
Indoles/pharmacology , Potassium Channels, Calcium-Activated , Potassium Channels/drug effects , Stroke/drug therapy , Animals , Brain/metabolism , CHO Cells , Calcium/metabolism , Cell Line , Cricetinae , Disease Models, Animal , Dogs , Glutamic Acid/metabolism , Humans , In Vitro Techniques , Indoles/pharmacokinetics , Indoles/toxicity , Large-Conductance Calcium-Activated Potassium Channels , Male , Patch-Clamp Techniques , Potassium Channels/metabolism , Rats , Rats, Sprague-Dawley , Rats, Wistar , Safety , Stroke/metabolism , Synaptic Transmission/drug effects
3.
J Neurosci ; 16(15): 4543-50, 1996 Aug 01.
Article in English | MEDLINE | ID: mdl-8764643

ABSTRACT

A human homolog of the large-conductance calcium-activated potassium (BK) channel beta subunit (hSlobeta) was cloned, and its effects on a human BK channel (hSlo) phenotype are reported. Coexpression of hSlo and hSlobeta, in both oocytes and human embryonic kidney 293 cells, resulted in increased Ca2+ sensitivity, marked slowing of BK channel activation and relaxation, and significant reduction in slow inactivation. In addition, coexpression changed the pharmacology of the BK channel phenotype: hSlo-mediated currents in oocytes were more sensitive to the peptide toxin iberiotoxin than were hSlo + hSlobeta currents, and the potency of blockade by the alkaloid BK blocker tetrandrine was much greater on hSlo + hSlobeta- mediated currents compared with hSlo currents alone. No significant differences in the response to charybdotoxin or the BK channel opener NS1619 were observed. Modulation of BK channel activity by phosphorylation was also affected by the presence of the hSlobeta subunit. Application of cAMP-dependent protein kinase increased P(OPEN) of hSlo channels, but decreased P(OPEN)of most hSlo + hSlobeta channels. Taken together, these altered characteristics may explain some of the wide diversity of BK channel phenotypes observed in native tissues.


Subject(s)
Benzylisoquinolines , Cyclic AMP-Dependent Protein Kinases/metabolism , Potassium Channels/physiology , Alkaloids/pharmacology , Amino Acid Sequence , Base Sequence , Calcium/physiology , Calcium Channel Blockers/pharmacology , Dose-Response Relationship, Drug , Humans , Molecular Sequence Data , Phenotype
4.
Mol Pharmacol ; 50(1): 206-17, 1996 Jul.
Article in English | MEDLINE | ID: mdl-8700114

ABSTRACT

Through expression of the cloned mouse (mSlo) or human (hSlo) large-conductance (BK) Ca(2+)-activated K+ channel in Xenopus laevis oocytes and HEK 293 cells, we characterized the effects of reported blockers and openers of BK channels to initiate the study of the molecular determinants of BK channel modulation. In oocytes, iberiotoxin and charybdotoxin, peptidyl scorpion toxins, were both equally effective blockers of BK current, although iberiotoxin was significantly more potent than charybdotoxin. The structurally related peptide kaliotoxin was not a potent blocker of BK current. Paxilline, a fungal tremorgenic alkaloid, was an effective but complex blocker of BK current. Tetrandrine, a putative blocker of type II BK channels, and ketamine were relatively ineffective. The putative BK openers NS004 and NS1619, phloretin, niflumic acid, flufenamic acid, and 5-nitro-2-(3-phenylpropylamino)benzoic acid (NPPB) increased BK current in oocytes at microM concentrations; many of these produced biphasic concentration-response relationships. Coapplication of representative blockers and openers revealed several patterns of interaction, including competitive and noncompetitive antagonism. NS1619, niflumic acid, and phloretin were tested by using excised inside-out membrane patches from HEK 293 cells and were found to increase the activity of hSlo BK channels and produce a leftward shift in the G/Gmax-versus-voltage relationship of these channels. These results represent the first comprehensive examination of the molecular pharmacology of BK channels.


Subject(s)
Benzylisoquinolines , Potassium Channels, Calcium-Activated , Potassium Channels/physiology , Alkaloids/pharmacology , Animals , Benzimidazoles/pharmacology , Cell Line , Charybdotoxin/pharmacology , Chlorophenols/pharmacology , Cloning, Molecular , Female , Humans , Indoles/pharmacology , Kidney , Kinetics , Large-Conductance Calcium-Activated Potassium Channels , Membrane Potentials/drug effects , Mice , Oocytes/drug effects , Oocytes/physiology , Patch-Clamp Techniques , Peptides/pharmacology , Phloretin/pharmacology , Potassium Channels/biosynthesis , Potassium Channels/drug effects , Recombinant Proteins/drug effects , Recombinant Proteins/metabolism , Scorpion Venoms/pharmacology , Xenopus laevis
5.
Neurobiol Aging ; 15(5): 629-33, 1994.
Article in English | MEDLINE | ID: mdl-7824055

ABSTRACT

Extracellular field recordings from CA1 pyramidal cells in the rat hippocampal slice preparation were used to examine the effects of age on gamma-aminobutyric acid (GABA)-mediated recurrent inhibition. The actions of bicuculline (1-100 microM), a GABAA antagonist, were assessed in slices from young (1-3 months) and aged (26 months) Fischer 344 rats. Pre-drug population spike amplitudes were smaller in slices from aged rats. Bicuculline increased population spike amplitudes in slices from both age groups, but slices from young rats were more sensitive to the antagonist. Bicuculline also produced multiple population spikes in slices from both age groups, however the increase in population spike burst durations was much greater in slices from young rats than in slices from aged rats. Agonist radiolabeled GABAA binding site density was significantly decreased in hippocampal tissue from aged rats. Our results suggest there is a reduction in GABAergic inhibition in hippocampal slices from aged rats, possibly mediated by a decrease in GABAA receptors.


Subject(s)
Aging/metabolism , Bicuculline/pharmacology , GABA-A Receptor Agonists , Hippocampus/metabolism , Animals , Bicuculline/pharmacokinetics , Electrophysiology , Evoked Potentials/drug effects , Hippocampus/drug effects , In Vitro Techniques , Kinetics , Muscimol/pharmacokinetics , Pyramidal Cells/drug effects , Pyramidal Cells/physiology , Radioligand Assay , Rats , Rats, Inbred F344 , Receptors, GABA-A/metabolism
6.
J Pharmacol Exp Ther ; 251(3): 810-6, 1989 Dec.
Article in English | MEDLINE | ID: mdl-2481033

ABSTRACT

The effects of three irreversible anticholinesterase agents, echothiophate (217MI), tertiary methylamine analog of 217MI (217AO) and Tetram, on end plate currents (e.p.c.s) of Rana pipiens cutaneous pectoris muscle were studied using electrophysiological techniques. All three compounds (217MI, 1-10 microM; 217AO, 1-25 microM; and Tetram, 1-50 microM) decreased the rate of e.p.c. decay (alpha) to the same extent as neostigmine (10 microM), a reversible anticholinesterase agent. Decay remained a single exponential at all membrane potentials. 217MI and its derivatives greatly reduced the normal voltage dependence of alpha represented by the slope (H = mV-1) of log alpha vs. membrane potential, in contrast to neostigmine which had no effect on H. Suppression of Ach release by the addition of 4 mM Mg++ to end-plates did not alter the reduction of H by 217AO indicating that the anticholinesterase-induced decrease in H is not simply due to an increased interaction between Ach and its receptors. Additionally, the pretreatment of end-plates with methanesulfonyl fluoride, also an irreversible cholinesterase agent, did not modify the effects of 217AO and Tetram on H. 217MI and its derivatives, at low concentrations which altered H, did not affect [3H]PCP or [125I]alpha-bungarotoxin binding to Torpedo californica Ach receptor-rich membranes. It is concluded that these agents alter H by an effect on the Ach receptor ion channel complex unrelated to either esterase inhibition or channel block.


Subject(s)
Cholinesterase Inhibitors/pharmacology , Echothiophate Iodide/pharmacology , Ion Channels/drug effects , Motor Endplate/drug effects , Neuromuscular Junction/drug effects , Receptors, Cholinergic/drug effects , Acetylcholinesterase/analysis , Animals , In Vitro Techniques , Ion Channels/physiology , Motor Endplate/physiology , Phencyclidine/pharmacology , Rana pipiens , Receptors, Cholinergic/physiology , Sulfones/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...